Skip to content

Preoperative Feeding With a Whey Protein Plus Carbohydrate Drink on the Acute Phase Response and Insulin Resistance

Effects of Preoperative Feeding With a Whey Protein Plus Carbohydrate Drink on the Acute Phase Response and Insulin Resistance.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01354249
Enrollment
20
Registered
2011-05-16
Start date
2010-07-31
Completion date
2010-10-31
Last updated
2011-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Phase Response, Insulin Resistance

Keywords

preoperative fasting, insulin resistance, carbohydrates, whey protein, inflammatory response

Brief summary

Prolonged fasting may increase the organic response to trauma. Carbohydrate-based drinks have been tested and they may reduce insulin resistance. No study so far has aimed to examine the possible benefits of whey protein drink in the composition of preoperative drinks.

Detailed description

The patients will be randomized into two groups: the carbohydrate-protein group (CHO-P) and the control group (CO). The patients will reeive a specific drink to their group on the evening prior to surgery and three hours before the operation. The CHO-P group will receive 474 ml (evening drink) or 237 ml (3h prior to operation drink) of a solution containing 14% whey protein (100% lactoalbumin), 86% carbohydrates (45% hydrolyzed corn starch and 55% sucrose) and 0% lipids (Resource® Breeze - Nestlé, São Paulo, Brasil) and the CO group will receive the same volume of water. Outcome measures On the day of the surgery and on the first postoperative day blood samples will be collected for glucose, insulin, triglycerides, albumin, pre-albumin, CRP, and α-1-acid glycoprotein (α-1-GA) assays. HOMA-IR will be calculated

Interventions

DIETARY_SUPPLEMENTwhey protein plus carbohydrate drink

The CHO-P group received 474 ml (evening drink) or 237 ml (3h prior to operation drink) of a solution containing 14% whey protein (100% lactoalbumin), 86% carbohydrates (45% hydrolyzed corn starch and 55% sucrose) and 0% lipids (Resource® Breeze - Nestlé, São Paulo, Brasil)

Sponsors

Federal University of Mato Grosso
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Adults (18-65 years-old) * Both sexes * Candidates to elective moderate operations such as open cholecystectomy, laparoscopic cholecystectomy and unilateral repair of inguinal hernia).

Exclusion criteria

* Acute cholecystitis * Diabetes mellitus * Chronic kidney failure * Chronic liver disease ot serum bilirubin greater than 2 mg/dL, body mass index (BMI) above 35Kg/m2 * American Anesthesiologists Association (ASA) score above 2 * Gastro-esophageal reflux * Gastroparesis or intestinal obstruction * Patients with any non-compliance with the study protocol, or who had associated operations, or presented significant intraoperative occurrences, or experienced prolonged operations (lasting more than 3 hours) were also excluded.

Design outcomes

Primary

MeasureTime frameDescription
insulin resistanceHoma-IR will be assessed in two time points: baseline (2-3 h before operatio) and 24h after operationInsulin resistance will be assessed by Homa-IR

Secondary

MeasureTime frameDescription
acute-phase responseAssays for the various acute-phase proteins will be done 2-3h before operation and 24 h after the operationAssays for albumin, pre-albumin, C reactive protein and α-1-acid glycoprotein

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 28, 2026